Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC33898101917;101918;101919 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
N2AB3225796994;96995;96996 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
N2A3133094213;94214;94215 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
N2B2483374722;74723;74724 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
Novex-12495875097;75098;75099 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
Novex-22502575298;75299;75300 chr2:178534923;178534922;178534921chr2:179399650;179399649;179399648
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: L
  • RefSeq wild type transcript codon: CTT
  • RefSeq wild type template codon: GAA
  • Domain: Kinase-1
  • Domain position: 86
  • Q(SASA): 0.1554
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
L/F rs371930491 None None N None 0.18 None gnomAD-4.0.0 2.74189E-06 None None None None N None 0 0 None 0 2.51991E-05 None 0 0 1.79894E-06 0 1.65722E-05
L/P rs1575286611 None None N None 0.34 0.484256599201 gnomAD-4.0.0 2.40067E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31252E-06 6.07607E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
L/A 0.3174 likely_benign 0.3274 benign -2.206 Highly Destabilizing None None None None None None None None N
L/C 0.6077 likely_pathogenic 0.6509 pathogenic -2.134 Highly Destabilizing None None None None None None None None N
L/D 0.8185 likely_pathogenic 0.8082 pathogenic -2.671 Highly Destabilizing None None None None None None None None N
L/E 0.5232 ambiguous 0.5219 ambiguous -2.583 Highly Destabilizing None None None None None None None None N
L/F 0.2453 likely_benign 0.2845 benign -1.54 Destabilizing None None None None N 0.495420223 None None N
L/G 0.6264 likely_pathogenic 0.6187 pathogenic -2.576 Highly Destabilizing None None None None None None None None N
L/H 0.3693 ambiguous 0.414 ambiguous -1.724 Destabilizing None None None None N 0.458248701 None None N
L/I 0.123 likely_benign 0.1206 benign -1.198 Destabilizing None None None None N 0.439316224 None None N
L/K 0.384 ambiguous 0.4056 ambiguous -1.619 Destabilizing None None None None None None None None N
L/M 0.1275 likely_benign 0.1482 benign -1.359 Destabilizing None None None None None None None None N
L/N 0.4683 ambiguous 0.48 ambiguous -1.77 Destabilizing None None None None None None None None N
L/P 0.7211 likely_pathogenic 0.6567 pathogenic -1.511 Destabilizing None None None None N 0.470735209 None None N
L/Q 0.2249 likely_benign 0.2641 benign -1.919 Destabilizing None None None None None None None None N
L/R 0.3223 likely_benign 0.3368 benign -1.096 Destabilizing None None None None N 0.440932377 None None N
L/S 0.3445 ambiguous 0.3571 ambiguous -2.391 Highly Destabilizing None None None None None None None None N
L/T 0.2534 likely_benign 0.2548 benign -2.183 Highly Destabilizing None None None None None None None None N
L/V 0.1225 likely_benign 0.1161 benign -1.511 Destabilizing None None None None N 0.45449632 None None N
L/W 0.4172 ambiguous 0.456 ambiguous -1.672 Destabilizing None None None None None None None None N
L/Y 0.5338 ambiguous 0.5981 pathogenic -1.425 Destabilizing None None None None None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.